Clinical Trial Update: Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring linperlisib plus chidamide in relapsed/refractory cutaneous T-cell lymphoma; current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• linperlisib plus chidamide

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cutaneous T-cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN